Extraordinary General Meeting at Meda

Extraordinary General Meeting at Meda Meda AB will be holding an extraordinary general meeting in Göteborg on 10 August 1999. This Annual General Meeting has been proposed by Volati BV, a company holding 2,533,863 shares, corresponding to 51.4 per cent of the share capital. Supported by this holding, Volati BV wishes to play a more active part in the management of Meda. Volati BV wishes to deal with the following issue at the Annual General Meeting: the election of two new members until the next ordinary annual general meeting will be held. Proposed as new members of the board are Karl Perlhagen and Lennart Perlhagen. An invitation to attend the extraordinary general meeting will be published in Svenska Dagbladet and the Swedish Official Gazette on Monday, 12 July 1999. For further information, please contact Annette Johansson Public Relations Manager Phone +46 31-701 29 04 or +46 70-445 03 00 Meda develops profitable partnerships in the Nordic and Baltic areas in collaboration with international producers of pharmaceuticals, nutrition and medical device products. With our thorough knowledge and our expertise in marketing and sales, we offer benefits to the health and medical care sector at the same time as we promote our own and our partner's growth and development. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/07/09/19990709BIT00400/bit0001.doc http://www.bit.se/bitonline/1999/07/09/19990709BIT00400/bit0002.pdf

About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.